Authors:
TANIMURA M
SHEVLYAGIN S
SHIMOYAMA H
STEINBERG MI
BORZAK S
GOLDSTEIN S
SABBAH HN
Citation: M. Tanimura et al., LY366634, A NOVEL SODIUM-CHANNEL ACTIVATOR, IMPROVES LEFT-VENTRICULARFUNCTION IN DOGS WITH CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 8094-8094
Authors:
TANIMURA M
SHEVLYAGIN S
SHIMOYAMA H
GOLDSTEIN S
SABBAH HN
Citation: M. Tanimura et al., EFFECTS OF COMBINED THERAPY WITH ACE-INHIBITION AND ANGIOTENSIN-II AT(1) RECEPTOR BLOCKADE IN MODERATE HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 99657-99657
Authors:
SABBAH HN
SHIMOYAMA H
TANIMURA M
SHEVLYAGIN S
BORZAK S
LEVINE TB
GOLDSTEIN S
Citation: Hn. Sabbah et al., INTRAVENOUS MIBEFRADIL, A T-TYPE CALCIUM-CHANNEL ANTAGONIST, IMPROVESCARDIAC HEMODYNAMICS IN DOGS WITH CHRONIC HEART-FAILURE - COMPARISON WITH DILTIAZEM AND PLACEBO, Circulation, 94(8), 1996, pp. 3255-3255
Authors:
SABBAH HN
SHIMOYAMA H
TANIMURA M
SHEVLYAGIN S
LEVINE TB
Citation: Hn. Sabbah et al., ORAL-THERAPY WITH OPC-18790 IMPROVES LEFT-VENTRICULAR FUNCTION IN DOGS WITH CHRONIC HEART-FAILURE, Circulation, 94(8), 1996, pp. 3648-3648
Authors:
SHIMOYAMA H
SABBAH HN
BORZAK S
TANIMURA M
SHEVLYAGIN S
SCICLI G
GOLDSTEIN S
Citation: H. Shimoyama et al., SHORT-TERM HEMODYNAMIC-EFFECTS OF ENDOTHELIN RECEPTOR BLOCKADE IN DOGS WITH CHRONIC HEART-FAILURE, Circulation, 94(4), 1996, pp. 779-784
Authors:
SHIMOYAMA H
SABBAH HN
TANIMURA M
SHEVLYAGIN S
BORZAK S
GOLDSTEIN S
Citation: H. Shimoyama et al., INTRAVENOUS BOSENTAN, AN ENDOTHELIN-1 RECEPTOR ANTAGONIST, IMPROVES CARDIAC-PERFORMANCE IN DOGS WITH CHRONIC HEART-FAILURE, Circulation, 92(8), 1995, pp. 143-143
Authors:
SHEVLYAGIN S
SHAROV VG
SAHAN G
SILVERMAN N
LESCH M
GOLDSTEIN S
Citation: S. Shevlyagin et al., DISPROPORTIONATE INCREASE IN CARDIOCYTE HYPERTROPHY IN MYOCARDIAL REGIONS BORDERING OLD INFARCTIONS - STUDIES IN PATIENTS AND DOGS WITH CHRONIC HEART-FAILURE, Circulation, 92(8), 1995, pp. 3811-3811